Year: 2025

Synchronoss Technologies Reports Fourth Quarter and Full Year 2024 Results

Written by Customer Service on March 11, 2025. Posted in Earnings Releases And Operating Results.

Fourth Quarter Revenue Grew 6.8% Year-Over-Year to $44.2 Million, Including 91% Recurring Revenue GAAP Gross Margin Expands to 69.1%; Adjusted Gross Margin Rises to 79.3% Announced Three-Year Contract Extension with Major U.S. Telecom Provider in December Unveiled Capsyl, a Turn-Key Personal Cloud Solution for Global Operators, in March 2025 BRIDGEWATER, N.J., March 11, 2025 (GLOBE NEWSWIRE) — Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in Personal Cloud platforms, today reported financial results for its fourth quarter and full year ended December 31, 2024. Fourth Quarter and Recent Operational HighlightsReported total revenue of $44.2 million, driven primarily by 6.0% cloud subscriber growth year-over-year. Quarterly results included net income of $7.9 million,...

Voyager Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Written by Customer Service on March 11, 2025. Posted in Earnings Releases And Operating Results.

– Tau silencing gene therapy VY1706 robustly reduced tau mRNA levels, with broad distribution, and was well-tolerated in NHP study; IND filing anticipated in 2026 – – Anti-tau antibody VY7523 was well tolerated in healthy volunteers and showed dose-proportional pharmacokinetics; initial tau PET imaging data in Alzheimer’s patients expected H2 2026 – LEXINGTON, Mass., March 11, 2025 (GLOBE NEWSWIRE) — Voyager Therapeutics, Inc. (Nasdaq: VYGR), a biotechnology company dedicated to leveraging genetics to treat neurological diseases, today reported fourth quarter and full year 2024 financial and operating results. “Over the past year, Voyager has significantly advanced our two wholly-owned programs targeting tau, which we view as the most important target in Alzheimer’s disease. Our anti-tau antibody VY7523...

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results

Written by Customer Service on March 11, 2025. Posted in Earnings Releases And Operating Results.

Phase 2 MaGic trial of DNTH103 in generalized Myasthenia Gravis (gMG) ongoing; top-line results on track for 2H’25 Phase 3 CAPTIVATE trial of DNTH103 in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) ongoing; interim responder analysis anticipated in 2H’26 Phase 2 MoMeNtum trial of DNTH103 in Multifocal Motor Neuropathy (MMN) ongoing; top-line results anticipated in 2H’26 $357.0 million of cash provides runway into 2H’27 NEW YORK and WALTHAM, Mass., March 11, 2025 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics to treat severe autoimmune diseases, today reported financial results for the fourth quarter and full year ending December 31, 2024 and provided an update on recent business achievements. “We...

High Wire Networks Cancels $10 Million Equity Line of Credit (ELOC)

Written by Customer Service on March 11, 2025. Posted in Public Companies.

The Move Minimizes Dilution, and the ELOC is Not Expected to be Necessary Post-Listing BATAVIA, Ill., March 11, 2025 (GLOBE NEWSWIRE) — High Wire Networks, Inc. (OTCQB: HWNI), a leader in managed services and technology solutions, announced the cancellation of its $10 million Equity Line of Credit (ELOC). The ELOC was part of a recent bridge financing package with a single investment fund. Mark Porter, President and CEO of High Wire Networks, stated, “As we look at the needs of our business going forward and the timing of all contemplated events, we feel that the ELOC is not in the best interest of our shareholders, and we do not expect it would be necessary from now on. After a short discussion, it was deemed mutually beneficial to cancel the ELOC on good terms, as we are mindful of dilution. Though it was part of the package,...

Kalmar Begins Sales of the OT2 EV Electric Terminal Tractor

Written by Customer Service on March 11, 2025. Posted in Public Companies.

Kalmar OT2 EVKalmar unveiled its third-generation OT2 EV Electric Terminal Tractor—fully designed and built in Kalmar’s Ottawa, Kansas facility—at the 2025 Technology & Maintenance Council Annual Meeting & Transportation Technology Exhibition in Nashville, Tennessee, USA March 10-12.Nashville, TN, March 11, 2025 (GLOBE NEWSWIRE) — Kalmar announces the official start of sales of the Kalmar Ottawa OT2 EV Electric Terminal Tractor (OT2 EV) at the Technology & Maintenance Council’s 2025 Annual Meeting & Transportation Technology Exhibition in Nashville, Tennessee, USA March 10-12, 2025. The OT2 EV represents Kalmar Ottawa’s third-generation electric terminal tractor and is fully designed and built in-house at the company’s Ottawa, Kansas facility. There are four different models available – two specifically...

TowneBank and Village Bank and Trust Financial Corp. Receive Regulatory Approvals for Merger

Written by Customer Service on March 11, 2025. Posted in Mergers And Acquisitions.

SUFFOLK, Va. and MIDLOTHIAN, Va., March 11, 2025 (GLOBE NEWSWIRE) — Hampton Roads based TowneBank (NASDAQ: TOWN) and Village Bank and Trust Financial Corp. (NASDAQCM: VBFC) (“Village”) today announced that the Federal Deposit Insurance Corporation and the Virginia State Corporation Commission have approved the regulatory applications filed in connection with TowneBank’s acquisition of Village and its wholly-owned subsidiary, Village Bank. In addition to the parties receiving all required regulatory approvals, the merger received the approval of Village’s shareholders, with more than 86% of the outstanding shares voting for the merger at Village’s special meeting of shareholders held on December 19, 2024. The merger is expected to be completed at the beginning of April 2025, subject to the satisfaction of customary closing conditions...

Kaldalón hf.: Annual General Meeting 2025 – Agenda and Board Proposals

Written by Customer Service on March 11, 2025. Posted in Public Companies.

The Board of Directors of Kaldalón hf. has convened the company’s Annual General Meeting on Wednesday, April 3, 2025, at 16:00 (GMT). The meeting will take place at Reykjavík Natura, Nauthólsvegur 52, 101 Reykjavík, Iceland. Enclosed are the agenda and the Board’s proposals for the Annual General Meeting. All relevant meeting materials are available at kaldalon.is/adalfundur2025. AttachmentKaldalón hf. – Dagskrá og tillögur stjórnar 2025

Priority Income Fund Announces Declaration of Preferred Stock Distributions for March 2025

Written by Customer Service on March 11, 2025. Posted in Dividend Reports And Estimates.

NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) — Priority Income Fund, Inc. (“Priority Income Fund” or the “Fund”) announced today that the Fund’s Board of Directors has declared distributions on shares of the Fund’s 7.00% Series D Term Preferred Stock due 2029 (“Series D”), 6.625% Series F Term Preferred Stock due 2027 (“Series F”), 6.000% Series H Term Preferred Stock due 2026 (“Series H”), 6.125% Series I Term Preferred Stock due 2028 (“Series I”), 6.000% Series J Term Preferred Stock due 2028 (“Series J”), 7.000% Series K Cumulative Preferred Stock (“Series K”), and 6.375% Series L Term Preferred Stock due 2029 (“Series L”). Ex-Dividend Date Record Date Payable Date Distribution per ShareSeries D March 24, 2025 March 24, 2025 March 31, 2025 $0.43750Series F March 24, 2025 March 24, 2025 March 31, 2025 $0.41406Series...

KONGSBERG awards NOK 109 million order to Kitron for tactical communication products

Written by Customer Service on March 11, 2025. Posted in Public Companies.

(2025-03-11) Kitron has received an order valued at NOK 109 million from Kongsberg Defence & Aerospace AS (KONGSBERG). The order covers communication equipment used in air defence systems delivered by KONGSBERG. “KONGSBERG has reported strong activity in its air defence projects, and we are very pleased to be part of its value chain in this growing market segment,” says Hans Petter Thomassen, VP Nordics & North America at Kitron. Deliveries are scheduled for 2026, with production taking place at Kitron’s facility in Arendal, Norway. For further information, please contact:Peter Nilsson, President and CEO, tel.: +47 948 40 850Hans Petter Thomassen, Executive Vice President, Nordics & North America, tel.: +47 913 92 360 E-mail: investorrelations@kitron.com Kitron is a leading Scandinavian electronics manufacturing services...

Danone publishes its 2024 Universal Registration Document

Written by Customer Service on March 11, 2025. Posted in Public Companies.

Press Release – Paris, March 11, 2025 at 7:15pm CET Danone publishes its 2024 Universal Registration Document Danone filed its 2024 Universal Registration Document with the French Financial Markets Authority (Autorité des Marchés Financiers) on March 11, 2025. The 2024 Universal Registration Document includes notably:the annual financial report; the Board of Directors’ report on the corporate governance; the description of the share buyback program; and the management report including sustainability information, the report on the certification of this information, as well as the vigilance plan.This 2024 Universal Registration Document is available to the public in accordance with applicable regulations and is also available on Danone’s website (www.danone.com), section Investors / Financial and extra-financial reports. The draft resolutions...

Year: 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals